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Abstract
Nurse practitioners (NPs/APRNs) who provide primary care services may be the first line
providers in situations where adults present with symptoms of memory loss and forgetfulness.
Though protocols are available for evaluating dementia, specific guidelines for evaluating early
cognitive changes, Mild Cognitive Impairment (MCI), are lacking. This descriptive research
project assesses the knowledge, current screening methods, and barriers to screening for MCI by
nurse practitioners (APRNs) in the state of Georgia. One hundred and thirty two NPs
participated in the survey. Forty-five percent of the participants were unfamiliar with the
diagnostic category of MCI. Of the major barriers identified, fifty eight percent of APRNs
identified not having enough time, thirty-four percent were unsure of the best screening methods,
and twenty percent of participants were unsure of protocols. Using Spearman rho correlation, MCI
screening was significantly correlated with completion of continuing education (CEUs) for both
MCI (rs = .245, p < .006) and dementia (rs = .243, p < .006). The Spearman’s rho revealed a
statistically significant relationship between MCI screening and routinely screening for
depression (rs = .478, p <.000). The second stage of this project was to develop practice
protocols for MCI. A practitioner panel was recruited from the participants in the initial survey.
The protocol and evaluation algorithm is presented and discussed.
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Chapter 1 Background and Significance of Proposed project/Intervention
Introduction
Alzheimer’s Dementia (AD) is an irreversible neurodegenerative disease characterized by
progressive memory deficits that interfere with daily functioning (Roberts et al., 2008).
According to the World Health Organization (2012), dementia is considered a major public
health problem of epidemic portion, affecting more that 35.6 million people worldwide.
Approximately 5.5 million people in the United States have Alzheimer’s Dementia or a related
dementia (WHO, 2012). Alzheimer disease is the sixth leading cause of death in the United
States (Thies & Bleiler, 2013). The disease impacts individuals and families and has been
estimated to cost the U.S. health care system in 2012 an estimated $200 billion, including $140
billion in costs to Medicare and Medicaid (Alzheimer's Association, 2012). As the number of
older adults increase in proportion to the total U.S. population, it can be expected that these costs
will increase exponentially. This number is expected to increase to an estimated 16 million by
2050 because of the United States aging population (Thies & Bleiler, 2013).
Mild cognitive impairment (MCI) is described as an intermediate stage of memory
disorder, involving more substantial memory and cognitive decline than normal aging changes
but less than the onset of dementia symptoms with its major pathologic changes (Defranceso et
al., 2010; Roberts et al., 2008). It is estimated that 12-15 % of MCI patients progress yearly to
AD compared to healthy older adults (Defranceso et al., 2010; Lopez et al., 2012; Peterson,
Knopman, & Boeve, 2009). Because MCI represents a significant risk factor for the
development of AD, older adults need to be screened early so that interventions can be started to
delay and possibly slow the potential progression to AD (Reardon & Halverson, 2013; Roberts et
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al., 2008). With the passage of the Affordable Care Act of 2010, a new Medicare benefit
requires an assessment of cognitive functioning in the older adult (Jeffrey, 2012; Patient
Protection and Affordable Care Act of 2010). Primary care nurse practitioners are expected to
identify and appropriately treat cognitive disorders as well as other underlying diseases and
provide the appropriate patient referrals for services and specialists. Primary care nurse
practitioners need to identify brief screening methods that have good sensitivity and specificity
for cognitive disorders. Additional education for nurse practitioners will be needed that focuses
on evidence based practice guidelines outlining appropriate treatments, resources, and referrals
available to patients and families. MCI practice guidelines will be vital to maintain and reduce
health care costs under the new Affordable Care Act. Screening, diagnosis, and treatment are
important because delaying nursing home placement for even one year could represent a savings
of $80,000 in nursing home costs (Genworth Executive summary, 2013).
Currently clinicians do not readily diagnose dementia during clinic visits using routine
history and physical examination. More than 76% of persons with dementia, including many
with mild but some with moderate dementia, have never received a diagnosis of dementia from a
physician or nurse practitioner (Boustani, Peterson, Hanson, Harris, & Lohr, 2003; Lin,
O’Connor, Rossom, Perdue, & Eckstrom, 2013). The lack of diagnosis of dementia suggests
insufficient current screening practices by primary care providers. The reason for the inadequacy
of screening is uncertain and may be associated with multiple factors such as time constraints
during visits, unawareness of current screening guidelines, insufficient knowledge of available
screening instruments, and uncertainty by providers in the administration and evaluation of these
screening instruments. No research was identified that addressed the reason for lack of diagnosis
or screening by primary care nurse practitioners.
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Problem Statement or Purpose
The purpose of this clinical project was to identify the need and advocate for nurse
practitioners to assess individuals in primary care for MCI. Nurse practitioners who are
providing primary care services are the first line providers in situations where adults present with
symptoms of memory loss and forgetfulness. The study investigated the knowledge, current
screening practices, and barriers to screening for Mild Cognitive Impairment in the older adult
population, aged 65 and older by nurse practitioners in the state of Georgia. Since the recently
passed Affordable Care Act requires yearly screening as part of the Wellness benefit for
Medicare, clinicians will need guidelines to insure quick and efficient methods of screening,
guidelines of treatment, and when to refer to specialists. Screening for MCI provides an initial
step towards progression of a correct diagnosis of MCI.
The first step in this translational project was to investigate the knowledge, barriers, and
screening methods used in clinical settings by nurse practitioners. From this data, practice
guidelines were developed, and in phase II, interested NPs from the survey were asked to
provide feedback and implement the newly developed protocol. There is a lack of information
for NPs to adequately screen for the diagnostic category of Mild Cognitive Impairment that often
precedes the diagnosis of dementia. This diagnostic category of MCI provides a target time to
initiate further evaluation of underlying medical conditions and to provide treatment in the
vulnerable older adult population.
Clinical Questions to be Addressed
Evidence based practice questions for this study include four areas of interest. The
questions are:
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1. What percentage of nurse practitioners currently screen for Mild Cognitive
Impairment yearly in the older adult population aged 65 and older?
2. What current screening practices for cognitive impairment are used to screen the
older adult, aged 65 and older?
3. What barriers do nurse practitioners identify in providing adequate screening for MCI
in the older adult population?
4. Which practice variables best explain the level of MCI screening of nurse
practitioners?

Theoretical Framework
Everett Roger’s Change Theory, diffusion of innovations was utilized as the conceptual
framework for this project. The theory provides a framework to promote the multilevel change
process necessary to affect change by addressing the inequities in screening and encouraging the
use and adoption of a new practice guideline or critical pathway (Rogers, 1965). Mild cognitive
impairment is a fairly new diagnostic category and many nurse practitioners may be unfamiliar
with MCI. The identification and assessment of the nurse practitioner’s knowledge of mild
cognitive impairment, current screening practices performed, and the perceived barriers to
screening are important areas to address in developing current practice guidelines for clinicians.
Roger’s theory describes the patterns of innovations/idea/program adoption, explains the
mechanism, and assists in predicting whether and how a new invention/idea/program will be
successful. Originally published in 1963, it is a descriptive tool providing guidance as to how to
promote the rate of innovation/program adoptions (Orr, 2003).
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Everett Roger’s theory is a broad based theory consisting of constructs from
psychology and sociology and has been used in health care, business, and informatics. The five
stages of change theory occur through a social system in a five- step process:
1. Awareness: the targeted population (nurse practitioners) must develop an
awareness or knowledge base of the idea/program/protocol (MCI, screening
method).
2. Interest: the population/clinicians develop an attitude toward the
idea/program/practice protocol (positive or negative).
3. Evaluation: population/clinicians decide whether to engage in the choice or
use/adopt the program/protocol.
4. Interpretation: population/clinicians implement the idea/program/protocol.
5. Adoption: population/clinicians confirm that the idea/program/protocol will be
provided (Orr, 2003; Rogers, 1965).
As more people or clinicians are exposed to an idea successfully, diffusion occurs
strengthening the impact of the idea. For example, at the individual level, adopting a health
behavior idea/innovation usually involves a lifestyle change. At the organizational level, it may
involve starting a program or changing regulations. At a community level, exposure or diffusion
can include using the media or advancing policies (Cain & Mittman, 2002). According to Rogers
(1965), a number of factors determine how quickly, and to what extent, an innovation will be
adopted and diffused. Diffusion is used to study the adoption of a health behavior and programs
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by health practitioners. Diffusions of innovations that promote health requires multilevel change
that usually takes place in diverse settings, through different strategies (Cain & Mittman, 2002).
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Chapter 2 Review of Literature and Synthesis
A review of the literature was conducted of English articles searching on the key words
of mild cognitive impairment, prevalence, screening, barriers, primary care, nurse practitioner,
clinical practice guidelines, and treatments in electronic databases. Databases included CINAHL,
Medline, Cochrane library, PROQUEST Nursing and Allied Health Sources, and PsychArticles.
Additional sources were identified in bibliographies of inclusion articles.
Demographic characteristics and risk factors of MCI
The prevalence rate for MCI varies from different population studies in different
countries. Based on Windblad’s clinical consensus criteria established in 2004, the prevalence in
the older adult of MCI in the United States is reported from 21.8% to 28.3% (Katz et al., 2012;
Manly et al., 2005; Manly et al., 2008; Peterson et al., 2010). Austria reports a similar MCI
prevalence rate to the United States of 24% (Fincher et al., 2007). China’s prevalence rate from
population studies is estimated from 12.7% to 21.3% (Nie et al., 2011; Xu et al., 2014). Busse,
Hensel, Guhne, Angermeyer, and Reidel-Heller (2006) report Germany’s MCI prevalence rate of
17.2% with a high MCI prevalence rate in France estimated at 42% (Aetero et al., 2008).
More recent research findings from the Memory and Medical Care Study population
study in 2011 with community-dwelling older adults, demonstrated a faster rate of cognitive
decline in MCI for African Americans when compared to non-African Americans (Lee et al.,
2011). Other population studies have revealed higher dementia rates in African Americans when
compared to Caucasians (Folstein, Bassett, Anthony, Romanoski & Nestadt, 1991; Heyman et
al., 1991; Schwartz et al., 2004; Zsembik & Peek, 2001). In the Einstein Aging Study (2012),
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there appeared to be little difference in MCI prevalence between men (22.2 %) and women
(21%) (Katz et al., 2012).
Several epidemiological studies have investigated the identification of MCI as a risk
factor towards development of Alzheimer’s dementia and found that dementia symptoms became
present in MCI patients in about two to three years before conversion (Ganguli, Dodge, Shen, &
DeKosky, 2004; Lopez et al., 2012; Roberts et al., 2008; Roberts et al., 2010). These cohort
studies suggest that the opportunity to identify MCI cases may be limited to begin therapies if
not identified early to treat underlying conditions for those patients who are more at risk to
convert to Alzheimer’s Dementia. Earlier treatment of vascular risk factors and management of
contributing underlying medical conditions may slow the progression, which has important
implications for the development of further preventive and interventional therapies. Since
increasing age is a risk factor for dementia, studies have suggested the importance of routinely
screening for cognitive changes over time (Ashford et al., 2008; Ganguli et al., 2004). The
Medicare Annual Wellness visit will insure yearly cognitive evaluations for the older adult.
Diagnostic Category of MCI
In 2004, the initial MCI standard diagnostic criteria was established at the international
workshop on Mild Cognitive Impairment in Stockholm (Winblad et al., 2004). The established
clinical consensus criteria included evidence of cognitive deterioration for age evidenced by
cognitive task performance and/or subjective complaints of memory decline by patient and/or
informant. The patient was not demented but not at the same cognitive level for persons in the
same age group, had preserved activities of daily living, and minimal to no impairment of
complex instrumental activities of daily living (Winblad et al., 2004).
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Patients identified with the diagnosis of MCI experience a mild decline in one or more
areas such as problems with “memory, attention, executive functioning, or visuospatial abilities”
(Albert et al., 2011, p.271). Basic activities of daily living and general intellectual functioning
remain intact. There may be minimal impairment of instrumental activities of daily living such
as managing finances, managing medications, driving, or grocery shopping (Aretouli & Brandt,
2010; DeVriendt et al., 2012; Wadley, Okonkwo, Crowe, & Ross-Meadows, 2008). These
patients often complain of memory problems and do not have any impairment in social function
(Feldman & Jacova, 2005; Gauthier et al., 2006; Peterson et al., 2010). The criteria for MCI falls
into two clinical subtypes of amnestic MCI (aMCI) and non-amnestic (naMCI) which has been
differentiated primarily for research purposes (Peterson et al., 2009). Amnestic MCI patients
present with memory impairment and non-amnestic patients present with impairment in a nonmemory area such as problems with attention, executive function, visuospatial ability, or
language (Ganguli et al., 2004; Gauthier et al., 2006; Peterson et al., 2009).
The Diagnostic and Statistical Manual (DSM-IV) criteria for dementia of the Alzheimer’s
type involves memory impairment and difficulties in one of the following areas: aphasia
(language problems), apraxia (impaired motor ability), agnosia (failure to recognize known
objects), or deterioration in executive function (complex tasks such as balancing a checkbook)
(American Psychiatric Association, 2000). Dementia refers to a “syndrome that includes a
deterioration of at least two cognitive functions, including memory, language, visuospatial
perception, and executive function” (Kiral, Ozge, Sungar, & Tasdelen, 2013, p. 89). According
to Kiral et al. (2013), as the disease progresses, neuropsychiatric symptoms appear along with
the memory impairment. Overall, the onset of dementia is gradual for most patients.
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Yanhong, Chandra, & Venkatesh (2013) provided a systematic review of the
neuropsychological deficits associated with MCI and the clinical importance for treatment (Level
I evidence). There is a wide range of deficits in memory and executive functioning in patients
with MCI. It is evident that more studies are needed to continue to identify specific impairments
that define MCI. As noted, MCI is associated with an increased risk of progressing to dementia
and continues to warrant specific diagnostic criteria.
Benefits of Early Screening
The importance of early screening for cognitive impairment is reinforced from the
requirement for screening as part of the annual Medicare Wellness visit (Cordell et al., 2013;
Jeffrey, 2012). From a cost perspective, initial screening can be inexpensive but the evaluation
of underlying contributing factors may be costly depending on the provider (Borson et al., 2013;
Jeffery, 2012). The data on improvement of patient outcomes is lacking either because the
outcomes were not measured, the study design was lacking, or there have been limited studies
specifically evaluating persons with MCI (Boustani et al., 2003; Lin, O’Connor, Rossom,
Perdue, & Eckstrom, 2013; Lin et al., 2013). Identifying conditions that are treatable such as B
12 deficiency, folic acid deficiency, hypothyroidism, and depression that may contribute to
cognitive changes in the older adult are beneficial to early screening (Borson et al., 2013;
Clarfield, 2003; Cotter, Clark, & Karlawish, 2003). According to Peterson et al. (2009), most
investigators believe that providers should treat underlying disease processes early and not wait
until functional impairment is noted. Failing to recognize early cognition changes in clients may
result in their performing at-risk behaviors such as operating machinery, driving difficulties, and
cooking (Ashford, 2008; Lin, Vance, Gleason, & Heidrich, 2012).
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Problems of Early Screening
Receiving a dementia diagnosis could have potential problems such as promoting
increased anxiety and depression with fears of a patient being able to remain independent.
Worry about losing one’s independence may include issues about continued job security, driving
privileges, social isolation from friends, or denial of insurance (Boustiani et al., 2011; Fowler et
al., 2012; Holsinger et al., 2011). According to Bouson et al. (2013), the potential harms do not
come from screening itself, but to the conditions uncovered or inaccurate interpretation of the
information obtained through screening. Potential problems from misdiagnosis of dementia can
be reduced with repeated screening (Lin et al., 2013). More importantly would be the
development of appropriate guidelines for additional evaluations, appropriate referrals, and
follow-up for early screening practices in those individuals who are screened for MCI.
In the recent review of the evidence for the U.S. Preventive Services Task Force, no
studies were found to confirm or rebut harms to screening (Lin et al., 2013). If clinicians are
concerned with the occurrence of false positives from screening, tools with a high specificity rate
should be used.
According to the U.S. Preventive Services Task Force, despite potential problems of
screening, there is some benefit for caregiver interventions and for medication treatment for AD.
Medication trials continue with mixed results for MCI to determine if there is a small benefit of
acetylcholinesterase inhibitors for treatment of MCI. There is some evidence to support
cognitive stimulation as a treatment for persons with MCI and mild to moderate dementia (Lin et
al., 2013).

NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT
17

Prevalence of Screening for Cognitive Impairment in Primary Care
In reviewing the existing literature, there were no studies investigating the prevalence of
screening methods used by nurse practitioners in primary care settings for cognitive impairment.
There were no studies specifically investigating the knowledge of advanced practice nurses in
screening the older adult and the use of the diagnostic category of MCI. MCI is a rather new
diagnostic category with a billing code established in October, 2008 in the International
Classification of Diseases, 9th revision, Clinical Modification (Center for Disease Control and
Prevention, 2011). This diagnostic code may be unfamiliar to primary care nurse practitioners if
not employed in specialty memory clinics or with neurology services who may evaluate
dementia patients frequently.
Barriers to Screening in Primary Care
Several studies have identified barriers to early diagnosing of dementia by physicians.
Physician concerns that are reported in the literature are time required for testing and counseling,
and concerns about the stigma associated with the diagnosis for patients and families (Boustani
et al., 2011; Bradford, Kunik, Schulz, William, & Singh, 2009; Justiss et al., 2009). Primary
care physicians may fail to diagnose early cognition changes because of failure to use efficient
screening tools and underreporting of symptoms by family members (Valcour, Masaki, Curb, &
Blanchette, 2000).
Additional studies have looked at barriers to screening for depression and a variety of
other medical conditions, however, no studies specifically address screening for MCI and nurse
practitioners. In screening patients for depression, clinicians identified the importance of having
clear protocols available for follow-up. Advanced practice nurses identified limited time in
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screening for depression, limited provider training, knowledge and lack of useful screening
instruments as barriers to depression screening (Burman, McCabe, & Pepper, 2005; Goldsmith,
2007). In medical screening for colonoscopies, clinicians including nurse practitioners,
identified barriers to screening as a lack of time and patient reluctance to screening as barriers
(Feely, Cooper, Foels, & Mahoney, 2009). Advanced practice nurses have consistently identified
time limits as a barrier to screening patients for skin cancer (Loescher, Harris, & CurielLewandrowski, 2011).
Considering these identified barriers to screening, having clear protocols, specific
guidelines as when to refer, and having useful efficient screening tools can contribute to
reinforcing the need for primary care clinicians to screen for early cognitive changes. Several
studies have identified the need for practitioners, physicians and nurses, to identify early subtle
cognitive changes in clients (Elliott, Horgas, & Marsiske, 2008; Roberts et al., 2010).
Screening Tools
There are brief instruments that can be used in primary care to detect dementia and in
considering their use for identifying early cognitive changes such as in MCI, higher specificity
and sensitivity is suggested. Regardless of the etiology of dementia, several instruments have
sensitivity and specificity rates greater than 80%. The following screening tools are available for
use with MCI screening.
Although there is no one suggested screening tool for MCI, there are several tools that are
sensitive to detect early cognitive changes when clients score within the normal range of the
Mini Mental Status Exam (MMSE). The MMSE is the screening test most frequently used for
dementia (Cordell et al., 2013). However, the MMSE is not sensitive enough for screening those
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with early cognitive changes and those patients will be missed for further work-up (Grober, Hall,
Liptom, & Teresi, 2008; Holsinger et al., 2012; Stewart, O'Riley, Edelstein, & Gould, 2012).
The Montreal Cognitive assessment (MoCA) is a screening tool designed to test for MCI
with a high sensitivity rate of 90% and a specificity rate of 87% (Cordell et al., 2013; Cullen,
O’Neill, Evans, Coen, & Lawlor, 2007; Nasreddine et al., 2005). This tool is specific in
identifying early cognitive changes in those individuals who perform in the normal range of the
Mini Mental Status Exam (MMSE). The MoCA assesses orientation, concentration, attention,
memory-short term and working, visuospatial ability, executive function, and language (Cordell
et al., 2013; Cullen et al., 2007; Nasreddine et al., 2005). The test can be administered in 10
minutes with a maximum score of 30 and a score of 25 or lower indicating below normal. The
test is free and can be accessed at www.mocatest.org.
The DemTect is also an easy to administer screening tool and is sensitive for identifying
early cognitive changes. It has a sensitivity rate of 80% and a higher specificity rate of 92%
(Cullen et al., 2007; Kalbe et al., 2004). Five tasks are measured including memory of word list,
delayed recall, word fluency, reverse of digits, and transcribing numbers. With a maximum
score of 18, scoring for MCI is from 9 to 12 points (Cullen et al., 2007; Kalbe et al., 2004).
The Memory and Executive Screening (MES) has a high sensitivity rate of 87% and
specificity rate of 91% in identifying early cognitive changes and the tool appears to be less
affected by education. The test does not require any reading or writing skills. The MES assesses
delayed recall, delayed memory, learning ability, executive function, and category fluency test.
The total possible score is 100 points with a score of 62-75 indicating probable MCI, dementia
correlated with a score of less than 62 (Guo, Zhou, Quian-hau, Wang, & Hong, 2012).
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The AB Cognitive Screen (ABCS) was shown to be more sensitive when compared to the
Mini Mental Status Exam (MMSE) in identifying early dementia changes (Grober et al., 2008).
This tool evaluates five cognitive areas: orientation, registration, delayed recall, clock drawing
and word fluency with a total score of 135 and 104 points indicating MCI (Molley, Standish, &
Lewis, 2005). The instrument has a sensitivity rate of 83% and a specificity rate of 91% (Molley
et al., 2005). This short screening tool was designed to differentiate normal cognitive changes
from MCI and dementia.
The St. Louis University Mental Status (SLUMS) is an 11 item screening tool that is easy
to administer and assesses several cognitive domains including attention, calculation, immediate
and delayed recall, animal naming, abstract thinking and visuospatial skill. It is more sensitive
than the MMSE in identifying mild neurocognitive disorder. It has been studied in the Veteran’s
population and has a sensitivity rate of 98–100% and specificity 98–100 for dementia with
adjustment for education but also has a cut off of 25 denoting mild neurocognitive disorder
(Tariq, Tumosa, & Chibnall, 2006). The SLUMS takes approximately 7 minutes to administer
with a maximum score of 30 points. Though the test needs to be studied in non-veteran
populations, it is recommended to practitioners by the Alzheimer’s Association for use in
detecting early neurocognitive changes (Cordell et al., 2013; Goy, Kansagara, & Freeman, 2010;
Tariq, et al., 2006; Stewart, O'Riley, Edelstein, & Gould, 2012). A comparison list of screening
tools for MCI is included in Table 1.
Treatment of MCI and Dementia
In consideration of treatment for MCI and dementia, this project is focused on the
screening of early cognitive changes in the older adult to identify and improve initial evaluation
and treatment for MCI. As noted, not all patients with positive screens for MCI will convert to
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Alzheimer’s Dementia. This early identification will alert providers to those clients at risk, and
to initiate further medical and neuropsychological work-up to insure appropriate diagnosis, and
to treat underlying conditions that affect cognition. Though outcome data is limited in studies
with MCI patients, continued research with this specific population is occurring and is providing
ongoing important clinical treatment data.
In treating dementia, a number of pharmacological and non-pharmacological
interventions have been available for clients and families. Nondrug interventions for clients
include cognitive stimulation, exercise, identifying polypharmacy and the possibility of adverse
side effects, nutritional education, and increased socialization (Geda et al., 2010; Holt, Stiltner,
& Wallace, 2009).
Pharmacological Interventions. Recent review of multiple drug studies demonstrated
evidence for the treatment of Alzheimer’s Dementia patients with cholinesterase inhibitors such
as donepezil, rivastigmine, and galantamine found that these medications were beneficial by
improving cognition in patients for up to three years. Additional positive benefits and outcomes
from these medications was the improvement of physical functioning as evidenced by the
improved performance of activities of daily living (ADLs) (Lin et al., 2013). The benefits for
MCI patients are unclear because of the small number of studies but the trials did show a
statistically significant benefit for donepezil and galantamine on improved cognition. With the
use of these medications, there was no benefit in the progression to MCI at one and three years
(Lin et al., 2013).
Treatment of Co-Morbidities. The co-morbidity of medical conditions is important to
identify when screening clients for mild cognitive impairment. Anemia has been identified as a
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predictor of dementia progression and can be easily identified and treated (Blossom, Stephan,
Brayne, Savva, & Matthews, 2011). Underlying contributing factors such as B12 deficiency,
hypothyroidism, and depression, which can affect cognition, and are all treatable conditions, may
improve cognition if identified early and treated appropriately (Blazer, 2009; Borson et al., 2013;
Clarfield, 2003). Both depression and cardiovascular diseases (CVDs) are risk factors for
cognitive impairment which need to be assessed and managed (Barnes, Alexopoulos, Lopez,
Williamson, & Yaffe, 2006). Vascular risk factors, such as hypertension, smoking,
cerebrovascular disease, diabetes mellitus, and atrial fibrillation, are also associated with late-life
cognitive decline (DeCarli et al., 2001; Kivipelto et al., 2001; Solfrizzi et al., 2004). All of these
risk factors need to be assessed and managed if indicated.
Cognitive Interventions. Stott & Spector (2010) provided a systematic review,
examining and evaluating memory interventions for MCI (Level I evidence). Though ten studies
were identified, there was no consistent evidence to support only one intervention. The studies
provided some evidence that memory interventions such as memory strategies, i.e., mnemonic
learning, computerized memory training can improve scores on pre and posttests (Hampstead et
al., 2008; Scott, & Spector, 2010). Patient mood, measured in three of the intervention studies,
did improve in all three which suggested a secondary benefit of providing some sense of control
and self-efficacy in participants’ lives when experiencing MCI. There is some evidence that it
can be helpful to teach internal and external memory strategies to people with MCI (Greenaway
et al., 2008; Hampstead et al., 2008; Troyer, 2001; Troyer, Murphya, Anderson, Moscovitchade,
& Craikde, 2008). Cognitive stimulation can also improve and reduce the decline of global
cognitive function in MCI patients at 6 and 12 months (Lin et al., 2013). The Advanced
Cognitive Training for Independent and Vital Elderly (ACTIVE) study demonstrated that
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cognitive training benefits were evident after ten years of initial reasoning and speed training
(Rebok et al., 2014). These findings suggest that cognitive training as an intervention may help
the older adult maintain and improve cognitive abilities. These long lasting benefits of cognitive
training will promote independence by sustaining activities of daily living.
Caregiver Interventions. Interventions geared towards caregivers including caregiver
support, case management, can improve caregiver burden (Lin et al., 2013). These interventions
included education about the condition and/or caregiving, caregiver training and skills to deal
effectively with dementia-related behaviors, and formal avenues of support such as respite
services, support groups. Earlier identification through screening identifying those at risk will
provide earlier avenues for dissemination of information about the condition to patients and
families, support groups, and advanced planning opportunities.
Exercise. The strongest evidence of lifestyle changes that may reduce the incidence of
AD is exercise. Three trials researching the benefits of exercise suggested a benefit in cognition
in MCI patients and persons with dementia at 12 and 18 months (Lin et al., 2013). Regular
exercise lowers specific brain markers in the brain, including reduced CSF tau and increased
CSF amulod, all markers of decreased AD risk (Liang et al., 2010). Both aerobic training (AT)
and resistance training (RT) enhance cognitive performance and functional plasticity, the ability
of the brain to change and adapt, in healthy, community-dwelling seniors (Nagamatsu et al.,
2012; Stelka, 2013). Exercise is a promising strategy for combating cognitive decline.
Maintaining a healthy BMI, body mass index, which is a measure of body fat based on
height and weight, also plays a role in general and cognitive health. Several research studies
demonstrate an association between being overweight with an increased risk of dementia
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(Narendran, Frankle, Mason, Muldoon, & Moghaddam, 2012; Xu et al., 2011). Weight
management and nutrition are important lifestyle changes to prescribe in managing vascular risk
factors.
With the initial screening efforts routinely administered during the annual visit, a
patient’s life style changes can be discussed with an emphasis on the importance of maintaining
and improving neurocognitive or brain health. Educational information can be presented with
healthier changes identified specific to the patient for improvement of cognition. Numerous
lifestyle factors are now being seriously considered by researchers and clinicians because of the
limited drug treatments available to slow the progression and lack of treatments to modify the
disease (Caracciolo, Weili, Collins, & Fratiglion, 2014; Lin et al., 2013; Stetka, 2013).
Screening Algorithm. The most recent recommendations from a systematic review, for
the required annual cognitive screening, is the development of a visit algorithm for the older
adult during the Annual Medicare Wellness visit (Cordell et al., 2013). The group developed a
step-wise approach to screen and evaluate for cognition status suggesting several screening tools
to assess dementia symptoms. In addition, the second step would be to review the Health Risk
Assessment that looks at subjective memory complaints or concerns, ADLs and IADLs. This
algorithm provides guidelines for clinicians of when to order further testing or when to refer
(Cordell et al., 2013). Expert guidelines have recommended along with the US Preventive
Services Task Force preventive task force to evaluate persons with any memory complaints or
concerns by informants (Boustani et al., 2003; Cordell et al., 2013). Early identification of
memory difficulties with documentation by a provider, may improve follow-up and medical care.
This time also serves as a beginning to discuss with patients who represent a population at risk
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for Alzheimer’s dementia about neurocognitive health (Cordell et al., 2013; Feil, MacLean, &
Sultzer, 2007).
It is evident from the synthesis of the literature that more outcome studies need to be
completed. More research is indicated in this evolving but very important area of early
screening. With the increased prevalence of dementia occurring in this country, the timeliness of
screening is vital for earlier treatment of risk factors and treatment of underlying medical
conditions.
Though more research is needed, possible benefits of earlier detection of MCI include
promoting better management of risk factors, delaying functional decline, providing education
and advanced planning for patients and families, delaying nursing home placement, and
identifying clients for inclusion in evolving drug and intervention trials (Elliott, Horga, &
Marsiske, 2008 [Level VI]; Roberts et al., 2010 [Level VI]; Stephan, Brayne, Savva, &
Matthews, 2011 [Level IV]).
Guidelines
Several agencies have recommended guidelines for cognitive screening based on
evidence. The focus of this project is screening for MCI, a risk factor for Alzheimer’s Dementia.
Recommendations from the US Preventive Services Task Force, the recent synthesis for the US
Preventive Services Task Force 2013, and the National Guideline Clearinghouse Practice
guidelines, best practices, are included.
US Preventive Services Task Force recommendations. The initial review by the US
Preventive Services Task Force (2003) found insufficient evidence in benefits for early detection
and treatment of dementia. The report did not recommend for or against routine dementia
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screening (Level I evidence). The report did indicate that assessment for cognitive function is
indicated when impairment was suspected. Patients who presented with memory complaints need
to be screened. Often patients with MCI present with memory impairment.
Systematic review for the US Preventive Services Task Force (USPSTF), October,
2013. The systematic review for the 2013 US Preventative Services Task Force found screening
improved limited benefits of outcomes for caregivers. However, the USPSTF concluded that
there is insufficient current evidence to determine the balance in benefits and harms of screening
for cognitive impairment (Lin et al., 2013). The reviewers reported that consensus groups and
expert guidelines “clearly believes that early diagnosis positively impacts important decisionmaking that ultimately will lead to improve patient outcomes and reduced future costs” though
there was no empirical evidence that screening improved decision making of patients or families
(Lin et al., 2013, p. 66). Their review is generally consistent with previous screening
recommendations, all persons who present with cognitive complaints, self-reported or through an
informant, should be screened for cognitive impairment (Lin et al., 2013). However, the
reviewers did report that experts agree that early detection of cognitive changes may be
beneficial to “optimize” medical treatments of underlying disorders, provide education about the
condition, encourage important decisions for planning for the future, and providing appropriate
referrals to needed services, all improving patient outcomes (Lin et al., 2013; Prince, Bryce, &
Ferri, 2011). They also reported the importance clinically to identify risk factors of persons at
high risk for cognitive impairments (Lin et al., 2013).
From the recent systematic review (2013), studies validate that brief instruments can
adequately screen for dementia. Six instruments were identified in more than one study to detect
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MCI. No studies were found to substantiate or disclaim harms to screening (Lin, O’Connor,
Rossom, Perdue, & Eckstrom, 2013).
National Guideline Clearinghouse Practice guidelines. Clinical practice guidelines
available to practitioners for cognitive assessment in the National Guideline Clearinghouse, was
recently updated in 2012. Though the target population in the guideline is hospitalized older
adults, the practice protocol provides a standard to screen and evaluate cognitive function in the
hospital as well as on the first visit to a new provider, and subsequently could be used in a
variety of settings such as family practice, long-term care, and assisted living. The guidelines are
included in the evidenced based geriatric nursing protocols for best practice that are intended to
be used by any practitioner (Milisen, Braes, & Foreman, 2012).
These initial research studies reinforce the need to develop protocols to screen for mild
cognitive impairment in the older adult aged 65 and older in primary care. The Affordable Care
Act requires assessment of cognitive functioning as part of the annual Medicare wellness visit. It
would be important to assess current screening methods, knowledge of mild cognitive
impairment, barriers to screening, and screening concerns to assist in developing MCI practice
protocols for nurse practitioners. Primary care nurse practitioners are pivotal in providing initial
screening, evaluation and treatment of vascular risk factors, treatment of co-morbid medical
conditions, and providing timely referrals for the older adult.
Though treatments and protocols are available for dementia, protocols for screening and
evaluation for mild cognitive impairment are limited. As evidenced in the literature, screening
tools are available that are sensitive and specific for mild cognitive impairment; but they are used
inconsistently or not at all in primary care. Risk factors that contribute to cognitive changes need
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to be assessed and underlying contributing conditions treated. Though pharmacological
treatment for MCI patients is inconclusive, the literature supports modest benefits from cognitive
interventions, treatment of co-morbidities, and continued monitoring of at risk patients.
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Chapter 3 Project Description
The purpose of this chapter is to describe the methods used. It will begin with the
purpose of the study, description of phase one and phase two, research questions identified,
sample criteria, description of the survey instrument, and the application of Roger’s theoretical
framework.
This project was a clinical practice-based inquiry that in phase I determined the
knowledge, current screening practices, and barriers to screening of older adults for MCI by
primary care nurse practitioners. This needs assessment provided data to assist in developing a
MCI screening protocol and evaluation treatment algorithm for nurse practitioners. After the
development of the MCI screening protocol, in phase II of the project, participants who indicated
an interest in the study were invited to participate in evaluating the implementation of the MCI
protocols in their practice. Members of the pilot study were also invited to implement the MCI
screening protocol and use of the evaluation algorithm in their practice. A practitioner panel was
developed that consisted of those NPs who agreed to provide feedback on the MCI practice
protocol.
Problem Statement or Purpose
Since the recently passed Affordable Care Act requires yearly screening as part of the
Wellness benefit for Medicare, clinicians need guidelines to insure quick and efficient methods
of screening, guidelines of treatment, and when to refer to specialists. Screening for MCI
provides an initial step towards progression of a correct diagnosis of MCI.
There is a lack of information for NPs to adequately screen for the diagnostic category of
Mild Cognitive Impairment that often precedes the diagnosis of dementia. This diagnostic
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category of MCI provides a target time to initiate further evaluation of underlying medical
conditions and to provide treatment in the vulnerable older adult population.
Clinical Questions to be Addressed
As presented in an earlier section, the evidence based practice questions for this study
include four areas of interest. The questions are:
1. What percentage of nurse practitioners currently screen for Mild Cognitive
Impairment yearly in the older adult population aged 65 and older?
2. What current screening practices for cognitive impairment are used to screen the
older adult, aged 65 and older?
3. What barriers do nurse practitioners identify in providing adequate screening for MCI
in the older adult population?
4. Which practice variables best explain the level of MCI screening of nurse
practitioners?

Methods
This project is a cross sectional study that utilized a web based survey administered to
nurse practitioners (NPs) in the state of Georgia. Participants were drawn from the Georgia
Board of Nursing mailing list.
Recruitment
All advanced practice nurses on the Georgia Board of Nursing mailing list were mailed a
postcard inviting them to participate in the survey. The online link to the survey was included in
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the information that was provided about the survey on the postcard (see Appendix A for postcard
invitation).
Inclusion Criteria
The subjects included in the study are advanced practice registered nurses with a
specialty in family practice, gerontology, or adult health who provide care to the older adult
population. The nurse practitioners who are currently employed in a variety of primary care
settings, clinics, private offices, and public health agencies are included.
Exclusion Criteria
Advanced practice nurses in Georgia who do not care for the target population or are not
currently working in the role of a nurse practitioner were excluded from the study. Advanced
practice nurses who do not reside in Georgia were excluded.
Sample
A major concern of the study was generating an appropriate response rate on which to
base clinical practice guideline development. Since the Georgia board of nursing does not
currently have a list of email addresses of nurse practitioners, a mailed invitation to an online
link was sent to NPs. Mailed invitations may not offer the most efficient method to invite and
encourage participation. A list of mailing addresses was available for a fee, and re-sending of
the invitation to participates is costly. Currently there are 6,172 NPs who are licensed in the state
of Georgia (Georgia Board of Nursing, 2014). No information is available regarding the sample
size of nurse practitioners who are currently employed in primary care or who provide services
to the older adult population.
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The response rate for web surveys tends to have lower response rates when compared to
other survey modes (Akl, Maroun, Klocke, Montori, & Schunemann, 2005; Leece et al., 2004).
The response rate for online surveys overall is approximately 33% as compared to mailed
surveys which averaged about a 56% response rate (Nulty, 2008). To address the response rate
concern, an additional effort was made by contacting the Georgia United Advanced Practice
Registered Nurses (UAPRN) speciality group to provide an invitation on their web site to
participate in the survey.
Survey Instrument
The 19 item survey was developed by the researcher and assesses the nurse practitioners
knowledge, current screening behaviors, and perceived barriers to screening patients for
cognitive disorders (See Appendices B and C). This survey focuses on the Awareness Phase of
Roger’s Change Theory.
Participant characteristics that were assessed include practice setting, certification,
attendance at continuing educational offering related to dementia, and personal family history of
dementia or MCI. The following demographic variables were obtained: age, gender, ethnicity,
employment status, and years of practice.
Questions were designed for the readability and clarity of advanced practice nurses. The
survey was pilot tested on a sample of 10 practicing NPs who provide care to the older adult
population. Their feedback was incorporated into the redesign and clarity of the survey
questions.
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Protection of Human Subjects
An application and request for approval to conduct this research was made with Georgia
College and State University’s Institutional Review Board. A waiver for signed consent was
requested because the web-based survey research is anonymous with no identifiable information
collected from the participants. A letter of implied consent was used in the survey instructions
(See Appendix B). The IRB required a modification to insure that the consent form preceded the
survey instrument to insure implied consent. There were no foreseeable risks involved in
participating in this survey research study other than those encountered in day-to-day life. The
results of this survey participation are anonymous.

Informed consent
This study is a web based anonymous survey for nurse practitioners in the state of
Georgia. The NPs were mailed an invitation to complete the survey online. A consent form was
included with the survey instructions explaining consent, risks and benefits of participating in the
survey research. By clicking to begin the survey, implied consent was given. By completing the
survey and submitting, the recipient consents to participate. This constitutes implied consent and
no identifiable information was collected from the participants (Refer to Appendix B). In the
survey, participants were asked if they would like to receive a copy of the protocols and if they
may be interested in following the screening guidelines in their practice. They may choose to
disclose their email address to the researcher and will no longer be anonymous. This data is
password protected and will be locked at the Macon Graduate Center for a period of three years.
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Data Analysis
Statistical analysis was performed using SPSS, version 21. Descriptive statistics was
used. For categorical data, frequencies and cross tabulations were performed. The association
among variables was assessed using Spearman Rank correlation.
After data analysis, this information was used to begin to address the multilevel change
process necessary to affect change by addressing the inequities in screening and encouraging the
use and adoption of a new practice guideline or critical pathway (Rogers, 1965). The five stages
of Roger’s change theory was used to complete the following stages of the project:
1. Increased Awareness: The information was used to target the population (nurse
practitioners) and help to develop an awareness or knowledge base of the
idea/program/protocol (MCI, screening method). The survey will increase
awareness for screening practices for MCI and identified the need for protocols.
2. Interest in screening protocol: the nurse practitioners/clinicians develop an attitude
toward the idea/program/practice protocol (positive or negative). From those nurse
practitioners who have an initial interest in the study, an email address was
requested. Those interested also have a choice of contacting the researcher for
additional information and to answer questions from the awareness that is
generated. From that individual contact, the nurse practitioners were invited to
participate in using the screening tools and protocols. From the interactions with
those interested, attitudes about the survey, screening tools and potential practice
protocols were initially determined.
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3. Evaluation: The nurse practitioners will decide whether to engage in the choice to
participate in the protocol development. From the information disseminated from
contacting those interested in the protocols, they will be asked to participate further
in the use of the screening instruments/protocols to provide assessment and
feedback.
4. Interpretation: The nurse practitioners will implement the idea. If agreed, the
interested nurse practitioners will implement the screening tools and use the
practice protocols in their practice. Feedback will help with the refinement of the
practice protocols and will be invaluable in continuing to improve the efficiency
and usefulness of the protocols. Phase II of feedback from protocol use in the
project is continuing and feedback is ongoing.
5. Adoption: Nurse practitioners will confirm if the idea is working. As
dissemination occurs among those using the screening tools and practice protocols
successfully, use of the protocols will strengthen the adoption process. Adoption is
more likely to occur within the practice settings. Effective and efficient use of the
screening instruments and protocols will continue to strengthen the adoption
process (Rogers, 1965; Orr, 2003).
Roger’s change theory provides a theoretical framework to assist in promoting change in
clinical practice. How can one effect change in practitioners to “buy in” early in a program to
screen older adults for mild cognitive impairment? By addressing the five stages of change
theory, the process helps to identify through a logical process the prediction if a new
idea/screening methods will be successful. Diffusion expands the number of people who are
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exposed to the idea, and is strengthened by the successful implementation of the screening
measures for MCI and use of the protocols (Rogers, 1965).
Use of the protocols by NPs in primary care will validate the administration of the
evidenced based screening tools and usefulness of the MCI evaluation algorithm. As more NPs
effectively screen, identify, and treat underlying causes of cognition changes in the older adult,
protocol use will be strengthened and more practitioners will be exposed to the tools and
algorithm promoting adoption among practitioners.

NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT
37

Chapter 4
Results
The purpose of this clinical project is to identify the need and advocate for nurse
practitioners to assess the older adult in primary care for MCI. MCI is a risk factor for the
development of Alzheimer’s Dementia and more than 75% of patients with mild to moderate
dementia are not diagnosed in primary care. There may be knowledge gaps in identifying early
cognitive changes in the older adult by nurse practitioners. The Affordable Care Act requires an
evaluation of cognition in the older adult during the annual Medicare Wellness visit. The NP
will need sensitive and specific screening tools that can be used efficiently in the primary care
setting as well an evaluation protocol for MCI which is lacking in the literature. As stated in
Chapter 1, the research questions which addressed the purpose of this descriptive study are:
1. What percentage of nurse practitioners currently screen for Mild Cognitive
Impairment yearly in the older adult population aged 65 and older?
2. What current screening practices for cognitive impairment are used to screen the older
adult, aged 65 and older?
3. What barriers do nurse practitioners identify in providing adequate screening for MCI
in the older adult population?
4. Which practice variables best explain the level of MCI screening of nurse
practitioners?
In phase I of the project, through the web based survey, the knowledge, current screening
practices, and barriers to screening for MCI in the older adult population, aged 65 and older, by
nurse practitioners in the state of Georgia were assessed. From this initial survey data and
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literature review, initial practice protocols were developed (See appendix D for MCI protocol
and evaluation algorithm). In phase II of the project, interested NPs in the survey who disclosed
their email address or contacted the researcher were sent the proposed MCI practice protocol and
evaluation algorithm for implementation and feedback. The initial stage of Phase II is complete;
however, feedback of protocol use is still being invited.
The survey data were first examined for error and inconsistencies and then analyzed
using frequencies and correlations. Descriptive statistics and correlations were used to answer
the clinical questions. Questions 1-3 were answered using frequencies and percentages, question
4 was answered using correlation. Data assumptions were met for use of the Spearman Rank
correlation. The following section describes the respondent samples, presents frequencies of
screening practices, and correlates variables associated with MCI screening.
Description of Sample
A total of 5,306 postcards were mailed to Georgia nurse practitioners, sixty six postcards
were returned by the postal service as undeliverable and 132 APRNs responded to the survey
with a 2.52% response rate. The researcher received 5 emails from APRNs who did not
participate in the study because they were not currently practicing an as NP or did not treat older
adults. These were subtracted from the initial postcard mailings reducing the mailed sample (N)
to 5235 nurse practitioners. One hundred forty (140) respondents initially agreed to participate in
the study, eight did not complete the survey, with a dropout rate of 5.7%. The total sample (N) is
132. Of the 132 respondents, 27% (n=35) identified themselves as adult NPs, 65% (n=85)
identified themselves as family NPs (FNPs), 8% (n=10) identified themselves as
geriatric/gerontological (GNPs), and 2 % (n=3) did not respond. Ninety nine (99%, n=131)

NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT
39

respondents indicated they were board certified with 84% (n=111) employed full-time and 16%
(n =21) employed as part-time working in a variety of practice settings including 42.4% (n=56)
working in primary care settings, 11.3% (n=15) in acute care clinics, 11% (n=14) working in
hospitals, 5% (n=6) employed in long term care facilities, 4% (n=5) in public health centers, and
4% (n=5) working in retail care clinics.
The sample of respondents were overwhelmingly female and the racial majority were
Caucasian with other ethnicities represented. Specifically, of the 132 participants, 8% (n=11)
were male and 92% (n=121) were female. The racial distribution of the sample consisted of 80%
Caucasian (n =105), 16% African American (n= 21), 2% (n =2) Hispanic and 3% (n=4)
identified as other. Thirty-five percent (n=46) of participants had less than five years in practice,
37% (n=49) had between five and fifteen years of practice experience, and 27% (n=36) had
greater than 15 years in practice. The age distribution consisted of 4% (n=5) were less than 30
years of age, 42% (n=55) were between the ages of 30-49, 45% (n=60) fell between 50-65 years
of age, and 9% (n=12) were over the age of 65 (See Table 2, for demographic descriptions).
Screening practices
When asked about screening practices, 50% (n=64) of the participants reported screening
for cognitive impairment routinely in the older adult and 65% (n=83) reported routinely
assessing for depression in the older adult. When screening for dementia 97% (n=120) were
familiar with the Mini Mental Status Exam (MMSE), 37% (n=46) were familiar with Mini-Cog
Memory, 11% (n=14) Memory Impairment Screen (MIS), 12% (n=15) were familiar with
Montreal Cognitive Assessment (MoCA), no respondents were familiar with the DemTect tool,
2% (n=2) were familiar with the General Practitioner Assessment of Cognition (GPC), 15%

NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT
40

(n=18) were familiar with Short Test of Mental Status (STMS), 8% (n=10) were familiar with
Alzheimer Dementia Screen for Primary Care, 1% (n=1) was familiar with Primary care AB
Cognitive Screen , 1% (n=1) was familiar with Memory and Executive Screen and 6% (n=8)
were familiar with the Six Item Screener (SIS).
Participants were also asked about routinely screening for depression because depression
in older adults may present as cognitive impairment. Twenty percent (n=25) of respondents
were not familiar with depression screening tools. Of those who screened for depression, 53%
(n=68) were familiar with the Beck Depression Inventory (BDI), 34% (n=44) were familiar with
the Geriatric Depression Scale (34%), 5% (n=6) were familiar with Cornell Scale for Depression
in Dementia (CSDD), and 37% (n=47) were familiar with the Patient Health Questionnaire
(PHQ).
Thirty two percent (n=41) of respondents reported that they did not screen for MCI. Of
those practitioners who screen for MCI, 58% (n=74) use the Mini Mental Status Exam (MMSE),
19% (n=24) use the Mini-Cog Memory Impairment Screen (MIS), 3% (n=4) use the Montreal
Cognitive Assessment (MoCA), 8% (n=10) indicated other tools including clock test, animal
naming, St. Louis University Mental Status (SLUMS), and family input.
Knowledge of Mild Cognitive Impairment
When participants were asked how familiar they were with the diagnostic category of
MCI, 16% (n=20) reported being very familiar, 40% (n=51) responded somewhat familiar, and
45% (n=58) indicated that they were not familiar with MCI. Thirty four (n=45) of respondents
had completed continuing education (CEUs) specific for Mild Cognitive Impairment (MCI) in
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the past five years with 89% (n=39) of those completing 1-15 CEU credits, 7% (n=3) completing
16-30 CEU credits, and 2% (n=1) completing greater than 30 CEU credits.
Forty one percent (n=54) had completed continuing education in other dementia
screening specific for Alzheimer’s Dementia, multi-infarct dementia, Lewy Body dementia in
the past five years. Ninety-four percent (n=49) completed 1-15 CEU credits, 4% (n=2)
completed 16-30 CEUs.
Barriers to Screening
When participants were asked to identify barriers to screening, 58% (n=75) reported not
having enough time, 33% (n=43) reported being unsure of best screening methods, 19% (n=25)
reported not having enough staff, 15% (n=20) reported that screening tools were too difficult to
administer efficiently, 20% (n=26) were unsure of protocols, and 20% (n=26) reported no
barriers to screening. Fifteen percent (n=19) reported other reasons identified as barriers
including lack of follow up for results, no clear guidelines in practice of what to do with test
results, cultural inconsistences, language definitions, patient reluctance, and must be government
approved (See Table 3 for a summary of identified barriers to screening).
Personal Involvement
Finally, respondents were asked if they had a personal experience with a family member
having dementia. Fifty nine percent (n=77) of participants indicated they had personal
experience of a family member with dementia.
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Correlations.
Analysis of the data was performed using SPSS, version 21. Correlations were compared
on the variables of MCI screening, age, specialty, years in practice, knowledge of MCI,
continuing education credits (CEUs), screening for depression, and personal experience of a
family member with dementia. Of all the variables correlated, only the following variables were
statistically significant. The Spearman’s rho revealed a statistically significant relationship of
MCI screening with completion of continuing education (CEUs) for both MCI (rs = .245, p <
.006) and dementia (rs = .243, p < .006). Those who completed CEUs for MCI and Dementia
were more likely to report that they screened for MCI. The Spearman’s rho revealed a
statistically significant relationship between MCI screening and routinely screening for
depression (rs = .478, p <.000). Those participants who were familiar and screened for MCI were
more likely to screen for depression. Having experience with a family member having dementia
was not significantly associated with MCI screening (See Table 4 for correlational data).
Protocol and Algorithm Evaluation.
In phase II of the project, additional data was collected about the interest of participants
in administering and providing feedback about the practice protocols that would be developed
for MCI. A systematic review of evidence of screening for and evaluation of mild cognitive
impairment in the older adult was performed to develop a screening and evaluation protocol for
MCI (See appendix D for MCI protocol and evaluation algorithm). During the pilot study, five
nurse practitioners agreed to follow the developed MCI screening and evaluation protocols
providing feedback. All five NPs reported the protocol was easy to follow, liked the information
provided on the screening tools, and liked the inclusion of the evaluation of recommended blood
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work studies. For each NP, the MoCA tool was administered to five patients during routine
physical exams. The NPs reported the ease of administration and scoring of the instrument
improved with use, initially requiring more time, but much less so as they became familiar with
the instrument and scoring. From the screening, one patient was referred to neurology and one
patient was found to have a medical condition contributing to cognitive changes. The St. Louis
University Mental Status (SLUMS) was administered to two patients and practitioners found the
tool to be easy and efficient to use, taking less than seven minutes to administer and score.
Twenty two respondents from the survey indicated interest in administering and
providing feedback about the screening tools suggested in the practice protocols by providing
their email addresses to the researcher. A copy of the MCI screening protocol and evaluation
algorithm were sent to all interested participants inviting their feedback. Six responses have
been received thus far, all positive comments, agreeing to use the protocols and treatment
algorithm as a guideline for screening and initial evaluation of cognitive impairment in older
adults. One email was undeliverable at the address given on the web survey resulting in 21
emails sent to interested APRNs. This second phase of the study consisting of feedback from use
of the screening protocol and evaluation algorithm is still ongoing. From the participation thus
far, dissemination of the MCI screening and evaluation protocol is occurring with potential
adoption in the future as more patients present with memory complaints or for their Medicare
annual visit.
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Chapter 5

Conclusions and Implications

Discussion of Evidence Based Questions
This descriptive study assessed the knowledge, current screening practices, and identified
barriers by Georgia nurse practitioners for screening of MCI in the older adult. From the areas
assessed, practice protocols were developed for use in primary care. In phase II of the study,
nurse practitioners interested in the development of practice protocols, were invited to comprise
a panel to implement the newly developed screening protocol and evaluation algorithm in their
practice providing feedback. Though the initial feedback of the implementation of the protocols
has been received, phase II of the project is ongoing to assess dissemination and adoption phases
of Roger’s change theory.
This section discusses the implications of the results presented in the previous chapter.
The first question relates to MCI screening practices, perceived barriers to screening, and
practice variables related to MCI screening. Next are recommendations related to the findings,
limitations, strengths of the study, implications of the study, and areas for future research
discussed. Each research question is listed with a discussion that follows.
Screening of MCI
What percentage of nurse practitioners currently screen for Mild cognitive Impairment
(MCI) yearly in the older adult population aged 65 and older?
Fifty percent of APRNs in this study screen for cognitive impairment with 32% report
they do not screen for MCI. Almost half of the respondents were unfamiliar with the diagnostic
category of MCI which may be a factor in MCI screening. APRNs may not separate MCI from
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other dementia screening which indicates that additional education efforts would help to increase
the understanding and screening for MCI.
For participants in the study, the implications of these data indicate that there are APRN
knowledge gaps of Mild Cognitive Impairment (MCI) and screening for cognitive impairments
in the older adult. People who have not received training or continuing education for dementia,
or more specifically, for MCI are not screening. The importance of continuing education and
exposure to information about MCI was shown to be important for practitioners to screen in their
practice. The number of older adults are increasing in the United States with the aging of the
Baby Boomer population. With the implementation of the Affordable Care Act 2010 and the
required assessment of cognition during the Medicare Annual Wellness visit, the expected
screening and management of dementia and more specifically MCI will be increasing. Having
tools specific and sensitive for MCI as well as an MCI evaluation protocol for guidelines are
important. Though specific guidelines are available for assessing dementia such as Alzheimer’s
Dementia, specific guidelines for assessing and evaluating MCI are lacking. Earlier
identification of cognition changes would promote more timely evaluations of treatable
dementias and appropriate referrals.
What current screening practices for cognitive impairment are used to screen the older
adult, aged 65 and older?
A variety of screening tools are used to screen the older adult for dementia and MCI. The
MMSE is the tool most frequently reported to screen for both dementia and MCI followed by the
Mini-Cog.

Both of these instruments are indicated for dementia screening but are not specific

or sensitive enough to screen for early cognitive changes as in MCI (Grober, Hall, Liptom, &
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Teresi, 2008; Holsinger et al., 2012; Kaufer et al., 2008). Identification of tools with a high
sensitivity and specificity rate indicated for MCI is important to ensure consistent screening
efforts in primary care.
Barriers
What barriers do nurse practitioners identify in providing adequate screening for MCI in
the older adult population?
The majority of respondents (58%) identified not having enough time as a major barrier
to screening, followed by unsure of best screening methods (34%). Twenty percent of the
APRNs/NPs were unsure of protocols, nineteen percent reported not having enough staff, and
sixteen percent identified that the screening tools were too difficult to administer efficiently. It is
interesting that twenty percent reported having no barriers to screening. The obvious is that time
is the major barrier indicating that quick and efficient screening methods should be adopted.
From the identification of barriers, a need for the development of protocols was indicated to
insure screening and appropriate follow-up (See Table 4 for summary of NP barriers to
screening). Specifically NPs identified a lack of clear guidelines.
Which practice variables best explain the level of MCI screening of nurse practitioners?
Only the completion of educational CEUs for dementia and MCI correlate with increased
screening for both MCI and dementia. The APRNs that participated in continuing education
units (CEUs) specific for MCI (rs = .245, p < .006) and other dementias (rs = .243, p < .006)
correlated significantly with increased screening efforts of the older adult. Knowledge of MCI
and screening for depression were strongly correlated to an increase in screening for MCI.
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Educational programs are needed to increase screening efforts for MCI in the older adult. No
other practice variable correlated with increased screening for the older adult.
It is very concerning and important to note that 20% of respondents were unfamiliar with
depression screening tools. A core competency in nurse practitioner curriculum is healthcare
screening measures which should include screening strategies and tools for depression. Graduate
schools of nursing may need to evaluate the competencies being addressed to insure this valuable
screening content is included. Only the completion of educational CEUs for dementia and MCI
correlate with increased screening for both MCI and dementia. Educational programs are needed
to increase screening efforts for MCI and depression in the older adult.
MCI Practice Protocol and Treatment Algorithm
Since dementia protocols are readily available, efforts in this study were focused on the
development of MCI protocols for use in primary care. Older adults are more likely to initially
present for yearly Medicare Wellness visits which now includes cognitive evaluations or will
present to their primary care provider with complaints of memory difficulties. From the research
data, the developed MCI screening protocol and treatment algorithm addressed the barriers,
identified evidenced based sensitive screening methods, and provided initial medical evaluation
guidelines including when to refer to neurology or memory disorder specialty clinics for further
evaluation. The protocol provides the provider with free to use, sensitive and specific MCI
screening tools and web resources for depression screening. Additional evidenced based
lifestyle changes which offer some limited benefit in patients with MCI are also included in the
protocol (See Appendix D for protocol and evaluation algorithm).
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Implications of the Study
From the assessment of the identified barriers in the study and in the development of the
practice protocol, two evidence-based screening tools, the Montreal Cognitive Assessment
(MoCA) and Saint Louis University Mental Status (SLUMS), are suggested for use in primary
care. Both screening tools are easy to administer taking 10 minutes or less and are free for use.
The SLUMS test can also be administered by ancillary personnel with minimal training reducing
the time needed by APRNs for direct screening. Both screening tools had a 90% or greater
specificity and greater than 80% specificity for MCI. Having efficient and sensitive tools as well
as practice guidelines are necessary to promote screening practices for MCI particularly in a busy
primary care office.
As important, from the findings of this study, increased continuing education
opportunities need to be offered for APRNs to improve knowledge of screening and evaluation
of cognitive impairments of the older adult. Additional education for APRNs to improve
knowledge of depression screening tools is also indicated from the research findings. Use and
adoption of the MCI practice protocols by those interested NPs identified in the survey remain an
ongoing phase of this study. The initial feedback received from the NPs indicates a useful
screening and evaluation protocol to follow in primary care.
Limitations
The major limitations of this study are the small sample size and low response rate. Only
mailing addresses were available from the Georgia Board of Nursing which limited recruiting
efforts of APRNs/Nurse practitioners. Postcards were returned despite checking for current
mailing addresses, and email addresses were not available. The largest number of nurse
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practitioners to obtain for this study was through the Georgia Board of Nursing listing. An
additional effort was made to increase the response rate by contacting the Georgia UAPRN
specialty group with a direct invitation on their website for NPs who care for older adults to
participate. Another limitation of this study may be the timing of the collection of data in the
busy summer months when people may not be readily accessible (Evaluation research team,
2010). The limited number of weeks for mailings and data collection decreased opportunities to
increase response rates such as attending state specialty conference meetings which are held
traditionally in the fall.
Strengths of the Study
This is the first study to develop a survey instrument to investigate the knowledge,
screening tools, and barriers to screening for Mild Cognitive Impairment by nurse practitioners.
With the development of practice protocols from the survey results, the dissemination of
screening for MCI during the annual Wellness visit will impact the care and outcomes for the
older adult.
Recommendations for Future Study
Recommendations for further study include improving the low response rate by
identifying other avenues for acquiring nurse practitioner listings for sampling such as specialty
web sites and social media. Of major importance would be to lobby for the Georgia board of
nursing to obtain current email addresses of all licensed APRNs so that continued research
efforts could be encouraged with better participation. Including all APRNs in further research
who treat the older adults would help to identify trends in screening and evaluation of MCI and
dementia.
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As the population continues to age and the frequency of MCI and dementia increases,
NPs will need to be prepared to use sensitive screening tools specific for MCI and have access to
guidelines for evaluation of MCI. Early screening efforts will promote earlier treatment of comorbid conditions, timely referrals for appropriate diagnosis, and interventions started to
possibly slow the progression of MCI to dementia. The ultimate goal is to improve the care of
the vulnerable older adult.
Conclusions
Findings from this translational project suggest that only half of the respondents in this
survey screen for cognitive impairment with almost fifty percent of APRNs being unfamiliar
with the diagnostic category of MCI. Most APRNs who screen for MCI use the Mini Mental
Status Exam (MMSE) as a major screening tool. Unfortunately, the MMSE has a ceiling affect
and is not specific enough to identify early cognitive changes. Though there were differences in
screening methods used, only a small percentage used tools very specific for MCI screening
including the MoCA and the SLUMS. The screening and practice protocol developed for this
project provides needed guidelines for screening and the initial evaluation of MCI.
Because of the use of a convenience sample, generalizability of the findings to NPs in
Georgia is limited. However, the data may indicate patterns in screening frequencies, knowledge
of MCI, and barriers to screening in practice.
Development of the MCI protocol and algorithm will provide guidelines for nurse
practitioners/APRNs to screen and initially evaluate older adults who present with memory
complaints or during the Medicare Annual Wellness visit which requires assessment of
cognition. Future use of the protocol and algorithm will validate its usefulness and reliability in
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primary care. Earlier identification of MCI can assist in identifying and treating co-morbid
conditions, obtaining correct diagnoses, providing patient and family education, and providing
more efficient and timely referrals with the ultimate goal of improving patient care outcomes of
the older adult.
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Table 1
Comparison of Screening Tools for MCI

Screening Tool

Sensitivity

Specificity

Administration Time

Montreal Cognitive Assessment
(MoCA)
DemTect

90%

87%

10 minutes

80%

92%

8-10 minutes

Memory Executive Screening (MES)

87%

91%

7-9 minutes

AB Cognitive Screen (ABCS)

83%

91%

3-5 minutes

St. Louis University Mental Status
92%
81%
7 minutes
(SLUMS)
Adapted from The Montreal cognitive assessment, MoCA: a brief screening tool for mild
cognitive impairment by Nasreddine, Z.S., Phillips, N.A., & Bedirian, V., 2005, Journal of
American Geriatric Society, 53(4), 695-699.; Adapted from Screening for mild cognitive
impairment: Comparing the SMMEE and the ABS by Molley, D.W., Standish, T.I., & Lewis,
D.L., 2005, Canadian Journal of Psychiatry, 50(1), 52-58; Adapted from Demtect: a new,
sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early
dementia by Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A.P., Brand, M., &
Bullock, R., 2004. International Journal of Geriatric Psychiatry 19(2), 136-43.; Adapted from
A brief cognitive test for detecting mild cognitive impairment by Guo, Q., Zhou, B., Qian-hau,
Z., Wang, B., & Hong, Z., 2012. BMC Neurology, 12(119). Adapted from Comparison of the
Saint Louis University mental status examination and the mini-mental state examination for
detecting dementia and mild neurocognitive disorder-a pilot study by Tariq, S.H. Tumosa, N., &
Chibnall, J.T., 2006. American Journal of Geriatric Psychiatry, 14(11), 900-910.
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Table 2
Participant Characteristics

Description of the Respondents (n=132)
Variable
Specialty
Adult
Family
Gerontological

Percentage %

27
65
8

Variable

Percentage %

Race
African American
Caucasian
Latin American
Other

16
79
2
3

Yrs. in Practice
< 5 years
5-15 years
> 15 years

35
37
28

Gender
Female
Male

92
8

Age Group
< 30 years
30 - 49 years
50 – 65 years
65+ years

4
42
45
9
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Table 3
Barriers to Screening

Reported Barriers to Screening (n=130)
Response

Percentage %

Not enough time

58%

Unsure of best screening methods

33%

Screening tools too difficult to
Administer efficiently

15%

Not enough staff

19%

Unsure of protocols

20%

Other

15%

No barriers

20%
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Table 4
Correlations Spearman Rank

Variable
MCI Screening

MCI
Screening
1

MCI CEU’s
Correlation Coefficient
Sig. (2 tailed)
N

.245**
.006
127

Dementia CEU’s
Correlation Coefficient
Sig. (2 tailed)
N

.243**
.006
127

Depression Screening
Correlation Coefficient
Sig. (2 tailed)
N

MCI CEU’s

Dementia CEU’s

Depression
Screening

1

1
.521**
.000
131
1
.478**
.000
125

.247**
.005
128

.254**
.004
128

**Correlation is significant at the 0.01 level. MCI CEUs = Mild Cognitive Impairment
continuing education units; Dementia CEUs=dementia (Alzheimer’s Dementia, multi-infract
dementia, Lewy Body dementia) continuing education units.
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Appendix A: Postcard Invitation
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Appendix B Letter for implied consent/Instructions that precede the web survey
You are invited to participate in a web-based online survey on current screening practices for
dementia. This is a research project being conducted by Margaret McIlwain, a DNP student at
Georgia College and State University. The purpose of the study is to develop practice protocols
for screening of mild cognitive impairment in the older adult. The survey should take less than
10 minutes to complete.
PARTICIPATION
Your participation in this survey is voluntary. You may refuse to take part in the research or exit
the survey at any time without penalty. You are free to decline to answer any particular question
you do not wish to answer for any reason.
BENEFITS
You will receive no direct benefits from participating in this research study. However, your
responses may help us learn more about what nurse practitioners need to help them screen for
cognitive impairments in a busy practice. From this research, practice guidelines may be
developed.
RISKS
There are no foreseeable risks involved in participating in this study other than those encountered
in day-to-day life.
CONFIDENTIALITY
Your individual responses will be anonymous and will not be released in any individually
identifiable form. Your survey answers will be sent to a link at Qualtrics.com where data will be
stored in a password protected electronic format where your responses will remain anonymous.
No one will be able to identify you or your answers, and no one will know whether or not you
participated in the study. At the end of the survey, you will be asked if you are interested in
administering and providing feedback about the screening tools suggested in the practice
protocols by contacting me by email at margaret.mcilwain@bobcats.gcsu.edu. If you choose to
provide contact information such as your phone number or email address, your survey responses
may no longer be anonymous to the researcher. However, no names or identifying information
would be included in any publications or presentations based on these data, and your responses
to this survey will remain confidential. Research at Georgia College involving human
participants is carried out under the oversight of the Institutional Review Board. If you have any
questions or concerns that you wish to address to someone other than the investigator, please
address questions to Dr. Bradley Koch, GC IRB Chair, CBX 018, GC, (478) 445-0937.
Electronic Consent: Please select your choice below. You may print a copy of this
consent form for your records. Clicking on the agree button indicates that you have read the
above information. You voluntarily agree to participate. You are 18 years of age or older.
(Source: http://iscs.gcsu.edu/forms.htm; http://www.mtu.edu/research/administration/integritycompliance/review-boards/human-subjects/consent_forms.html)

NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT
73

Appendix C: Survey Instrument: Screening Practices of NPs
Nurse Practitioner Survey
1.

Gender:
Male _____
Female _____

2.

Age group:
<30 years _____
30–49 years _____
50–65 years _____
65+ years ______

3.

Race:
Caucasian _____
African American _____
Hispanic_____
Other ______

4. Work Schedule:
Full time _____
Part time _____
5. Board Certified:
Yes _____
No _____
6. Specialty:
Family ______
Adult ______
Geriatric_____
Other______
7.

Years in Practice:
<5 _____
5- 15 _____
>15 _____

8. Practice Setting:
Primary Care Office_____
Acute Care Clinic _____
Hospital_____
Public Health Center______
Retail Care Clinic (CVS Minute Clinic, Walgreens) _____
Other_________
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9.

Percentage of patients seen for primary care ________
Percentage of patients aged 65 years and older ________

10. Have you completed any Continuing Education (CEU’s) specific for mild cognitive
impairment (MCI) screening in past five years?
Yes ______
No ______
If yes, approximate number of credits earned:
None _____
1—15 ______
15-30 ______
> 30 ______

11.

Have you completed any Continuing Education (CEU’s) in other dementia screening
(Alzheimer’s Dementia, multi-infarct dementia, Lewy Body dementia) in the past five
years?
Yes____
No____
If yes, approximate number of credits earned:
None _____
1—15 ______
15-30 ______
> 30 ______

12.

Do you routinely assess for cognitive impairment in the older adult?
Yes _____
No _____

13. Are you familiar with the following instruments that can be used for screening for
cognitive impairment/Dementia? Please check all that apply.
Mini Mental Status Exam (MMSE): Yes_______ No_____
Mini-Cog: Yes_______ No______
MIS: (Memory Impairment Screen) Yes_____ No______
MoCA: (Montreal Cognitive Assessment) Yes______ No_____
Dem Tect: Yes______ No_____
GPC: (General Practitioner Assessment of Cognition) Yes_____ No_____
STMS: (Short Test of Mental Status) Yes_____ No_____
Alzheimer Dementia Screen for Primary Care: Yes_____ No_____
AB Cognitive Screen: Yes_____ No_____
Memory and Executive Screen: Yes_____ No_____
Other___________
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14. Are you familiar with the diagnostic category of Mild Cognitive Impairment (MCI)?
Yes, very familiar _____
Yes, somewhat familiar _____
No _____
15. Which of the following tools do you use in your practice to screen for Mild Cognitive
Impairment (MCI)? Select all that apply.
None, do not screen: ______
Mini Mental Status Exam (MMSE): Yes _____ No_____
Mini-Cog: Yes _____ No_____
MIS (Memory Impairment Screen): Yes _____ No_____
MoCA (Montreal Cognitive Assessment): Yes _____ No_____
Dem Tect: Yes______ No_____
Other___________
16. Do you routinely assess for depression in the older adult?
Yes _____
No _____
17. Are you familiar with the depression screening tools? If yes, please check all that apply.
Beck Depression Inventory (BDI): Yes _____ No_____
Geriatric Depression Scale (GDS): Yes _____ No_____
Cornell Scale for Depression in Dementia (CSDD): Yes _____ No_____
Patient Health Questionnaire (PHQ): Yes _____ No_____
Other__________
If yes, what screening methods do you use?
Beck Depression Inventory (BDI): Yes_____ No______
Geriatric Depression Scale (GDS): Yes _____ No_____
Cornell Scale for Depression in Dementia (CSDD): Yes _____ No_____
Patient Health Questionnaire (PHQ): Yes _____ No_____
Other____________
18. What types of barriers to screening for cognitive impairments have you experienced in
your practice?
Not enough time_____
Unsure of best screening methods_____
Screening tools too difficult to administer efficiently_____
Not enough staff_____
Unsure of protocols______
Other_____________
No barriers ______
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19. Have you had personal experience of a family member with dementia?
Yes_____
No _____

Thank you for your time in completing this survey. Your responses are very important in the
development of practice protocols. If you are interested in administering and providing feedback
of the screening tools recommended in the practice protocols, please contact me at
margaret.mcilwain@bobcats.gcsu.edu. or provide an email address and I will contact you.
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Appendix D: Evidence Based Practice Protocol and Evaluation Algorithm

Screening for Mild Cognitive Impairment (MCI) in older adults
I.

GOAL:
A. To provide initial screening for early cognitive changes
B. To monitor cognitive changes in the older adult over time
C. To monitor treatment response
With the passage of the Affordable Care Act of 2010, a Medicare benefit requires yearly assessment of
cognitive functioning in the older adult (Cordell et al., 2013; Patient Protection and Affordable Care Act
of 2010). Early screening for MCI is suggested (Borson et al., 2013).
II.

Definition:
Mild cognitive impairment (MCI) is described as an intermediate stage of memory disorder,
involving more substantial memory and cognitive decline than normal aging changes but
less than the onset of dementia symptoms (Defranceso et al., 2010; Roberts et al., 2008).
It is estimated that 12-15 % of MCI patients progress yearly to Alzheimer’s Dementia (AD)
compared to healthy older adults (Defranceso et al., 2010; Peterson, Knopman, Boeve, &
2009). MCI represents a significant risk factor for the development of AD. Older adults
need to be screened early so that modifiable risk factors can be addressed, underlying
conditions that may affect cognition treated, and early referrals can be initiated for
appropriate diagnosis (Borson et al., 2013; Roberts et al., 2008).

III.

Incidence
The prevalence rate for MCI varies from different population studies. The estimated
prevalence of MCI ranges from 3-42% of older adults depending on the definition (Lin,
O’Conner, Rossom, Perdue, & Eckstrom, 2013; Ward, Arrighi, Michels, & Cedarbaum, 2012).

IV.

Etiology
MCI loss is more cognitive decline than is expected for someone of similar age and does not
meet the diagnostic criteria for dementia.
Major subtypes:
A. Amnestic MCI often converts to AD and has been found to have underlying
pathology similar to AD (Markesbery et al., 2006).
B. Non-Amnestic MCI may have no underlying pathology or be secondary to
cerebrovascular disease, Lewy body dementia, frontotemporal dementia.
(Parks, Decarli, Jacoby, & Yonelinas, 2010).

V.

Clinical Features
A. Memory difficulties, often patients present with complaints of memory loss
B. Disturbance in language such as difficulty in finding appropriate words, naming
C. Disturbance in attention, for example difficulty in following conversations
D. Difficulties in visuospatial skills (disorientation in familiar surroundings)
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E. Basic ADLs are intact but patients may have difficulty with more demanding IADLs such
as handling finances, driving or shopping
(Albert et al., 2011; Aretouli & Brandt, 2010; Gauthier et al., 2006; Wadley, Okonkwo,
Crowe, & Ross-Meadows, 2008).
VI.

Screening Tools specific for MCI or Mild neurocognitive Impairment:
A. MoCA (Montreal Cognitive Assessment) Sensitivity, 90%, specificity 87%, administration
time approximately 10 minutes (Nasreddine, Phillips, & Bedirian, 2005).
Free for use.
B. St. Louis University Mental Status (SLUMS) Sensitivity 92%, specificity 81%,
administration time approximately 7 minutes (Tariq, Tumosa, & Chibnall, 2006).
Free for use.
If MCI screening is positive, assess mental status and screen for depression. Depression
is a risk factor for MCI (Blazer, 2009; Gao et al., 2013; Saczynski et al., 2010).
Suggested screening tool for Depression: Geriatric Depression Scale, 92% sensitivity
89% specificity (GDS developed by Yesavage et al., 1983).

VII.

Physical Examination
Review history of memory complaints, assess vascular risk factors, nutritional status,
medications. Evaluate sleep patterns, insomnia, sleep apnea. Consider drug and alcohol
history.
Corroborate if informant present.
Identify sensory deficits, hearing and vision.
Perform physical exam.

VIII.

Laboratory Studies
Initial work-up: CBC, B12 level, thiamine, folic acid, thyroid function tests, electrolytes,
glucose, BUN/creatinine, liver function tests, U/A. Consider VDRL, HIV, drug screen if risk
factors identified (American Geriatrics Society, 2010; Reuben, Herr, Pacala, Pollock, Potter,
& Semla, 2011).

IX.

Treatment
Treat underlying potential causes of cognition changes such as B12 deficiency, anemia,
thyroid disease, depression. Treat or refer for identified sensory deficits.
Provide patient education of lifestyle modifications that show some limited benefit:
A. Mediterranean Diet (Caracciolo, Weili, Collins, & Fratiglion, 2014; Roberts et al.,
2010; Sofi, Macchi, Abbate, Gensini, & Casini, 2010). Mediterranean diet
emphasizes vegetables, fruits, whole grains, nuts, unsaturated fats.
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B.

Regular exercise (Liang, Mintun, Fagam, & 2010; Lin et al., 2013; Nagamatsu et al.,
2012) Studies report moderate physical exercise such as brisk walking, strength or
resistance training, use of exercise machines, aerobics.

C. Cognitive stimulating activities (Hampstead et al., 2008; Lin et al., 2013; Rebok et al.,
2014; Stott, & Spector, 2011) Studies suggest mentally stimulating activities such as
computer games, computerized memory training, crossword puzzles.
X.

Follow-Up: Indicated by initial screening, physical examination, treatment of potential
causes of cognition changes, and laboratory studies. If any concerns persist, consider neuroimaging of CT scan of brain or MRI for further evaluation or refer to neurology or memory
clinic for early dementia work-up (American Geriatrics Society, 2010).

XI.

Consultation-Referral: If assessment is positive for MCI after treatment of potential causes,
refer to neurology and/or memory clinic for comprehensive neurological evaluation and
neuroimaging.

Resources
Recommended Instruments for Assessing Mild Cognitive Impairment (MCI):
MoCA (Montreal Cognitive Assessment)
Access at: http://www.mocatest.org OR
http://consultgerirn.org/uploads/File/trythis/try_this_3_2.pdf
St. Louis University Mental Status (SLUMS)
Access at: http://medschool.slu.edu/agingsuccessfully/pdfsurveys/slumsexam_05.pdf
Recommended Instruments for Assessing Depression in the older adult:
Geriatric Depression Scale
Access at: http://consultgerirn.org/uploads/File/trythis/try_this_4.pdf
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